Skip to content
DataLookout
Menu

NCT07744997

Radicle RestTM VGI: A Study Assessing the Impact of Health and Wellness Products Gene III® L-Ergothioneine Capsules and Gene III® L-Ergothioneine on Sleep and Related Health Outcomes

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 17 words Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 500 participants (planned 600)
    • Primary completion date changed from estimate of Aug 6, 2027 to Nov 5, 2026
    • Study title expanded, about 8 words
  2. Minor Enrollment closed, study ongoing
    • Start date changed from estimate of Aug 6, 2026 to Aug 11, 2026
    • Site details revised
    v3
  3. Notable Recruitment opened
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change in sleep
Timeframe: 7 weeks

Secondary (3)

Change in sleep-related impairment
Change in mood (emotional distress-depression)
Change in fatigue

Arms and interventions

Active Rest Product 1Experimental

Active Rest Product 1

Placebo Rest ControlPlacebo comparator

Placebo Rest Control

Dietary supplements: Placebo Rest Control, Active Rest Product 1

Sites

1 site in 1 country

  • Radicle Science Inc.Del Mar, California, United States